No Data
No Data
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Express News | Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Express News | Arcutis Announces Promotions on Executive Management Team
Press Release: Arcutis Announces Promotions on Executive Management Team
Arcutis Biotherapeutics, Inc.'s (NASDAQ:ARQT) 43% Share Price Surge Not Quite Adding Up
Mizuho Securities Keeps Their Buy Rating on Arcutis Biotherapeutics (ARQT)
No Data